Cancer-specific quality of life questionnaires: The state of the art in Europe

European Journal of Cancer Part A

Volumn 33, Issue SUPPL. 6, 1997, Pages

  Cull, A M ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cancer clinical trials; Quality of life

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER PATIENT; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; HEALTH SURVEY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0030871613     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00194-9     Document Type: Article

References (36)

1. Editorial. Quality of life and clinical trials. Lancet 1995, 346, 1-2.
2. Gill TM, Feinstein AR. A critical appraisal of the quality of life measurements. JAMA 1994, 272, 619-626.
3. Berzon RA, Simeon GP, Simpson RL, Donnelly MA, Tilson HH. Quality of life'bibliography and indexes: 1993 update. Qual Life Res 1995, 4, 53-74.
4. Smets EMA, Garssen B, Bonke B, de Haes JCJM. The multidimensional fatigue inventory: psychometric qualities of an instrument to assess fatigue. J Psychosomat Res. 1995, 39, 315-325.
5. Fayers PM, Jones DK. Measuring and analysing quality of life in cancer clinical trials: a review. Stat Med 1983, 67, 361-370.
6. Osoba D. Self-rating symptom checklists: a simple method for recording and evaluating symptom control in oncology. Cancer Treat Rev 1993, 19(A)), 43-51.
7. McHorney CA, Tarlov AR. Individual patient monitoring clinical practice: are available health status surveys adequate? Qual Life Res 1995, 4, 293-307.
8. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand 1983, 67, 361-370.
9. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994, 30A, 37-40.
10. Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 Quality of Life Questionnaire through combined Qualitative and Quantitative Assessment of Patient/Observer Agreement. J Clin Epidemiol 1997, 50, 441-450.
11. Gelber RD, Godhirsch A, Cole BF. Evaluation of effectiveness: Q-TWIST. Cancer Treat Rev 1993, 19(A), 73-84.
12. Aaronson NK, Cull A, Kaasa S, et al. The EORTC modular approach to quality of life assessment in oncology. Int J Mental Health 1994, 23, 75-96.
13. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure, J Clin Oncol 1993, 11, 570-579.
14. Aaronson NK, Ahmedzai S, Bullinger M. The EORTC core quality of life questionnaire: interim results of an international field study. In Osoba D, ed. The Effect of Cancer in Quality of Life. Boca Raton FL, CRC Press Ltd., 1991, 185-203.
15. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85, 365-375.
16. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the EORTC Core Quality of Life Questionnaire. J Clin Oncol 1995, 13, 1249-1254.
17. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian, and lung cancer. Qual Life Res 1994, 3, 353-364.
18. Osoba D, Aaronson NK, Zee B, te Velde A, Sprangers MAJ. Modification of the EORTC QLQ-C30 based on reliability testing in large samples of patients with cancer. Qual Life Res 1995, 4, 4684.
19. Sprangers MAJ, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European Organisations for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 1993, 2, 287-295.
20. Sprangers MAJ, Groenvold M, Arraras J, et al. The European Organisation for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire Module: First Results from a Three Country Field Study. J Clin Oncol 1996, 14, 2756-2768.
21. Bjordal K, Ahlner Elmqvist M, Tollesson E, et al. Development of an EORTC questionnaire module to be used in quality of life assessments in head and neck cancer patients. Acta Oncol 1994, 33, 879-885.
22. Blazeby JM, Alderson D, Winstone K, et al. Development of an EORTC Questionnaire Module to be used in Quality of Life Assessment for patients with oesophageal cancer. Eur J Cancer 1996, 32A, 1912-1917.
23. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC-QLQ-LC13: a modular supplement to the EORTC QLQ-C30 for use in lung cancer trials. Eur J Cancer 1994, 30A, 635-642.
24. Zee B, Pater J, Osoba D. Global health related quality of life: a direct measurement vs aggregate scores. Qual Life Res 1995, 4, 506.
25. Groenvold M, Bjorner JB, Klee MC, Kreiner S. Test for item bias in a quality of life questionnaire. J Clin Epidemiol 1995, 48, 805-816.
26. Fayers P, Aaronson NK, Bjordal K, Sullivan M. EORTC QLQ-C30: Scoring Manual. Brussels, EORTC Publications, 1995.
27. Fayers P, Curran D, Machin D, on behalf of the EORTC Quality of Life Study Group. Incomplete Quality of Life Data in Randomised Trials: Missing Items. Stat Med, in press.
28. Zwinderman AH. Statistical analysis of longitudinal quality of life data with missing measurements. Qual Life Res 1992, 1, 219-224.
29. King M. The interpretation of scores from the EORTC Quality of Life Questionnaire QLQ-C30. Qual. Life Res 1996, 4, 555-567.
30. Sprangers MAJ, Broerson J, Lodder L. The need to control for response shift in longitudinal quality of life research. Qual Life Res 1995, 4, 488.
31. Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res 1996, 5, 496-502.
32. Osoba D. The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organisation and functions. Qual Life Res 1992, 1, 211-218.
33. Sigle JM, Porzsolt F. Computer system for measurement of quality of life data. Prog Palliative Care 1995, 3, 92.
34. Sneeuw KCA, Aaronson NK, Sprangers MAG, et al. The value of care givers ratings in evaluating the quality of life of patients with cancer. J Clin Oncol, 1997, 15:3, 1206-1217.
35. Sigurdardottir V, Brandberg Y, Sullivan M. Criterion based validation of the EORTC QLQ-36 in advanced melanoma: the CIPS questionnaire and proxy raters. Qual Life Res 1996, 5, 375-386.
36. Sneeuw KCA, Aaronson NK, Osoba D, et al. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care, 1997, 35, 490-506.